Glucocorticoids in spondyloarthritis-systematic review and real-world analysis.
Arghya ChattopadhyayDebasish MishraJoydeep SamantaPublished in: Rheumatology (Oxford, England) (2021)
There were limited studies on either systemic or local injections of GCs in SpA. However, there was good evidence of efficacy with the use of high-dose systemic GCs in the short term (≤6 months) in SpA. Both IA and entheseal injections seemed safe and effective.